Nick Waddell is the Founding Editor at Cantech Letter. He focuses on finance, trading, and business economics, with a particular emphasis on capital markets, economic policy, and investment strategies. His insights and analyses have been featured in various outlets, showcasing his expertise in the financial markets and the broader economy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Nick Waddell's coverage predominantly focuses on investment analysis and cites data extensively. He covers topics such as stock market movements, analyst recommendations, Canadian stocks, and inflation.
Given this focus, Nick would likely be most receptive to pitches that offer unique insights into the Canadian stock market or provide detailed analytics supporting sales and marketing strategies within the realm of investments. Additionally, he may be interested in expert opinions related to specific companies or sectors within Canada.
Since his geographic focus is national (Canada), relevant information should pertain to Canadian markets or have implications for investors within the country.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Research Capital analyst Andre Uddin has maintained his “Speculative Buy” rating and $0.70 target on Theralase
Paradigm Capital analyst Daniel Rosenberg has reiterated his “Buy” rating and $0.10 target on Snipp
Beacon Securities analyst Gabriel Leung maintained his “Speculative Buy” rating on Hydreight but lowered his target to $8.00 from $10.00
Keywood said patient recruitment remains a major bottleneck and cost driver in drug development, creating a potential opportunity for AI-based patient matching.
RBC senior economist Claire Fan said RBC continues to expect domestic demand to support further labour market improvement into 2027
Analyst Greg McLeish has reiterated his “Speculative Buy” rating and $3.00 target on Futr
Roth Capital Partners analyst Suji Desilva has maintained his “Neutral” rating on Ambarella and lowered his target to US$65.00 from $90.00
“Our neutral view is primarily due to the continued elevated organic revenue declines in both its IMG and AMG businesses,” Kwan said.
Roth Capital Partners analyst Suji Desilva has maintained his “Neutral” rating on Ambarella and lowered his target to US$65.00 from $90.00
“Our neutral view is primarily due to the continued elevated organic revenue declines in both its IMG and AMG businesses,” Kwan said.
